×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CRSP – crispr therapeutics ag - common shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CRSP
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/20
09:44 am
crsp
1 big new Green Flag for CRISPR Therapeutics' Stock [Yahoo! Finance]
Low
Report
1 big new Green Flag for CRISPR Therapeutics' Stock [Yahoo! Finance]
12/20
08:55 am
crsp
CRISPR Therapeutics AG (NASDAQ: CRSP) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $86.00 price target on the stock.
Low
Report
CRISPR Therapeutics AG (NASDAQ: CRSP) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $86.00 price target on the stock.
12/19
07:49 am
crsp
Capsida Biotherapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Low
Report
Capsida Biotherapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
12/18
09:01 am
crsp
Celebrating a Milestone: Engineering Tomorrow Reaches 1 Million Students [Yahoo! Finance]
Medium
Report
Celebrating a Milestone: Engineering Tomorrow Reaches 1 Million Students [Yahoo! Finance]
12/17
05:42 am
crsp
2 Growth Stocks That Could Rocket Higher in 2025: Are They Right for Your Portfolio? [Yahoo! Finance]
Low
Report
2 Growth Stocks That Could Rocket Higher in 2025: Are They Right for Your Portfolio? [Yahoo! Finance]
12/16
12:27 pm
crsp
EDIT Stock Falls on Decision to End Reni-Cel Studies, Cut Workforce [Yahoo! Finance]
Low
Report
EDIT Stock Falls on Decision to End Reni-Cel Studies, Cut Workforce [Yahoo! Finance]
12/14
09:58 am
crsp
3 Things You Need to Know if You Buy CRISPR Therapeutics Today [Yahoo! Finance]
Low
Report
3 Things You Need to Know if You Buy CRISPR Therapeutics Today [Yahoo! Finance]
12/11
11:03 pm
crsp
CRISPR Therapeutics AG (NASDAQ: CRSP) was upgraded by analysts at StockNews.com to a "sell" rating.
Medium
Report
CRISPR Therapeutics AG (NASDAQ: CRSP) was upgraded by analysts at StockNews.com to a "sell" rating.
Date
Time
Symbol
Company Name
Action
%Chg
11/5/2024
09:01 am
crsp
crispr therapeutics ag - common shares
BEAT
Report
0.6%
crispr therapeutics ag - common shares
8/5/2024
04:01 pm
crsp
crispr therapeutics ag - common shares
MISS
Report
-0.7%
crispr therapeutics ag - common shares
5/9/2024
04:02 pm
crsp
crispr therapeutics ag - common shares
BEAT
Report
-4.0%
crispr therapeutics ag - common shares
5/8/2024
04:11 pm
crsp
crispr therapeutics ag - common shares
BEAT
Report
-1.0%
crispr therapeutics ag - common shares
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/10
01:35 pm
crsp
Form SC 13G/A CRISPR Therapeutics AG Filed by: ARK Investment Management LLC
Low
Report
Form SC 13G/A CRISPR Therapeutics AG Filed by: ARK Investment Management LLC
12/4
05:35 pm
crsp
Form 4 CRISPR Therapeutics AG For: Dec 02 Filed by: Kulkarni Samarth
Medium
Report
Form 4 CRISPR Therapeutics AG For: Dec 02 Filed by: Kulkarni Samarth
11/13
05:35 pm
crsp
Form 4 CRISPR Therapeutics AG For: Nov 11 Filed by: Kulkarni Samarth
Medium
Report
Form 4 CRISPR Therapeutics AG For: Nov 11 Filed by: Kulkarni Samarth
11/12
09:41 am
crsp
Form 144 CRISPR Therapeutics AG Filed by: Kulkarni Samarth
Medium
Report
Form 144 CRISPR Therapeutics AG Filed by: Kulkarni Samarth
11/5
09:11 am
crsp
Form 10-Q CRISPR Therapeutics AG For: Sep 30
Low
Report
Form 10-Q CRISPR Therapeutics AG For: Sep 30
11/5
09:05 am
crsp
Form 8-K CRISPR Therapeutics AG For: Nov 05
Low
Report
Form 8-K CRISPR Therapeutics AG For: Nov 05
10/18
05:35 pm
crsp
Form 4 CRISPR Therapeutics AG For: Oct 16 Filed by: KASINGER JAMES R.
Low
Report
Form 4 CRISPR Therapeutics AG For: Oct 16 Filed by: KASINGER JAMES R.
10/18
05:35 pm
crsp
Form 4 CRISPR Therapeutics AG For: Oct 16 Filed by: Bruno Julianne
Low
Report
Form 4 CRISPR Therapeutics AG For: Oct 16 Filed by: Bruno Julianne
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
11/19
CRISPR Therapeutics down 4% premarket on initial CTX001 data [Seeking Alpha]
19.1%
2/28 Can CRISPR Therapeutics Double Your Money in 2020? [The Motley Fool] 13.1%
10/28 Q3/2019 9/30/2019 EPS 2.400 ZacksConsensus N/A ActVsEst N/A - N/A 12.5%
8/5 Form 4 CRISPR Therapeutics AG For: Aug 01 Filed by: Ho Tony W 7.5%
2/7 First CRISPR Gene Editing Trial in Cancer Patients Shows Promising Results [The Motley Fool] 6.8%
12/2 Form 4 CRISPR Therapeutics AG For: Dec 01 Filed by: Kulkarni Samarth 6.3%
11/22 Form 8-K CRISPR Therapeutics AG For: Nov 19 6.1%
10/30 Crispr Therapeutics AG (NASDAQ: CRSP) was upgraded by analysts at TheStreet from a "d" rating to a "c" rating. 5.9%
6/6 Form 8-K CRISPR Therapeutics AG For: Jun 06 5.6%
4/24 Form DEF 14A CRISPR Therapeutics AG For: Jun 11 5.5%
2/28 Can CRISPR Therapeutics Double Your Money in 2020? [The Motley Fool] 13.1%
10/28 Q3/2019 9/30/2019 EPS 2.400 ZacksConsensus N/A ActVsEst N/A - N/A 12.5%
8/5 Form 4 CRISPR Therapeutics AG For: Aug 01 Filed by: Ho Tony W 7.5%
2/7 First CRISPR Gene Editing Trial in Cancer Patients Shows Promising Results [The Motley Fool] 6.8%
12/2 Form 4 CRISPR Therapeutics AG For: Dec 01 Filed by: Kulkarni Samarth 6.3%
11/22 Form 8-K CRISPR Therapeutics AG For: Nov 19 6.1%
10/30 Crispr Therapeutics AG (NASDAQ: CRSP) was upgraded by analysts at TheStreet from a "d" rating to a "c" rating. 5.9%
6/6 Form 8-K CRISPR Therapeutics AG For: Jun 06 5.6%
4/24 Form DEF 14A CRISPR Therapeutics AG For: Jun 11 5.5%
TOP News Decliners
11/20
CRISPR Therapeutics Announces Pricing of Public Offering of Common Shares
-10.6%
3/31 Form 8-K CRISPR Therapeutics AG For: Mar 31 -10.4%
8/3 Crispr Therapeutics AG (NASDAQ: CRSP) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -10.2%
12/27 Form 8-K CRISPR Therapeutics AG For: Dec 27 -7.5%
12/6 Crispr Therapeutics AG (NASDAQ: CRSP) had its "buy" rating re-affirmed by analysts at Wells Fargo & Co. -7.1%
2/21 Crispr Therapeutics AG (NASDAQ: CRSP) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. -6.5%
10/1 CRISPR Therapeutics to Present at Upcoming Investor Conferences -6.3%
9/25 Is CRISPR Therapeutics a Buy? [The Motley Fool] -5.9%
2/13 Crispr Therapeutics AG (NASDAQ: CRSP) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $72.50 price target on the stock. -5.6%
6/19 Form 4 CRISPR Therapeutics AG For: Jun 17 Filed by: Kulkarni Samarth -5.6%
3/31 Form 8-K CRISPR Therapeutics AG For: Mar 31 -10.4%
8/3 Crispr Therapeutics AG (NASDAQ: CRSP) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -10.2%
12/27 Form 8-K CRISPR Therapeutics AG For: Dec 27 -7.5%
12/6 Crispr Therapeutics AG (NASDAQ: CRSP) had its "buy" rating re-affirmed by analysts at Wells Fargo & Co. -7.1%
2/21 Crispr Therapeutics AG (NASDAQ: CRSP) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. -6.5%
10/1 CRISPR Therapeutics to Present at Upcoming Investor Conferences -6.3%
9/25 Is CRISPR Therapeutics a Buy? [The Motley Fool] -5.9%
2/13 Crispr Therapeutics AG (NASDAQ: CRSP) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $72.50 price target on the stock. -5.6%
6/19 Form 4 CRISPR Therapeutics AG For: Jun 17 Filed by: Kulkarni Samarth -5.6%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: